Hunan Creator Information Technologies
300730
Shandong Rike Chemical
300214
Jiangsu LiXing General Steel Ball
300421
4
Jiangsu Boiln Plastics
301003
5
Ningbo Henghe Precision Industry
300539
US Stock MarketDetailed Quotes
PFE Pfizer
- 26.740
- +0.090+0.34%
Close Feb 25 16:00 ET
- 26.721
- -0.020-0.07%
Post 19:59 ET
151.54BMarket Cap18.96P/E (TTM)
27.030High26.540Low43.56MVolume26.720Open26.650Pre Close1.17BTurnover0.77%Turnover Ratio18.96P/E (Static)5.67BShares30.55252wk High1.64P/B151.31BFloat Cap23.71352wk Low1.68Dividend TTM5.66BShs Float53.002Historical High6.28%Div YieldTTM1.84%Amplitude5.306Historical Low26.794Avg Price1Lot Size
About Pfizer Company
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Company Profile
SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees88000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323
Websitehttp://www.pfizer.com
Company Executives
- Name
- Position
- Salary
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 21.56M
- Dr. G. Mikael Dolsten, M.D.
- Chief Scientific Officer and President, Pfizer Research and Development
- 8.86M
- Rady A. Johnson
- Chief Compliance, Quality and Risk Officer and Executive Vice President
- --
- Aamir Malik
- Chief Commercial Officer, U.S. and Executive Vice President
- 5.42M
- Michael McDermott
- Executive Vice President and Chief Global Supply Officer
- --
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 5.28M
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Dr. Chris Boshoff, M.D.,PhD
- Executive Vice President and Chief Oncology Officer
- --
- Lidia L. Fonseca
- Chief Digital and Technology Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Douglas M. Lankler
- Executive Vice President and General Counsel
- 5.48M
- Mortimer J. Buckley
- Director
- --
- Cyrus Taraporevala
- Director
- --
- Suzanne Nora Johnson
- Independent Director
- 410.00K
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 410.00K
- Joseph J. Echevarria
- Independent Director
- 390.00K
- James C. Smith
- Independent Director
- 390.00K
- Shantanu Narayen
- Lead Independent Director
- 430.00K
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 417.20K
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 391.40K
- Ronald E. Blaylock
- Independent Director
- 380.00K
- James Robert Quincey
- Independent Director
- 380.00K
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 363.00K
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 360.00K
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets.
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites